An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Transcat, Inc. to Present at Sidoti Virtual Micro Cap Investor Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Transcat, Inc. (NASDAQ: TRNS) will participate in the Sidoti Virtual Micro Cap Investor Conference on December 8, 2021. CEO Lee D. Rudow and CFO Mark A. Doheny will present at 9:15 a.m. ET and are available for investor meetings. A link to the live webcast and presentation materials can be found on their investor relations page. Transcat specializes in accredited calibration, repair, inspection, and laboratory services, catering to regulated industries such as Life Sciences and Aerospace.
Positive
None.
Negative
None.
ROCHESTER, N.Y.--(BUSINESS WIRE)--
Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that Lee D. Rudow, President and Chief Executive Officer, and Mark A. Doheny, Chief Financial Officer, will present and be available for investor meetings at the Sidoti Virtual Micro Cap Investor Conference on Wednesday, December 8, 2021. The Transcat presentation is scheduled to begin at 9:15 a.m. Eastern Time. A link to the live webcast, along with presentation materials, will be available at www.transcat.com/investor-relations. A replay of the webcast will be available for 90 days.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection, and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found at: Transcat.com.
